SSS

SHUKRA PHARMACEUTICALS LIMITED

No trades
See on Supercharts
Market capitalization
‪3.93 B‬INR
‪44.07 M‬INR
‪588.34 M‬INR
Beta (1Y)
4.00

About SHUKRA PHARMACEUTICALS LIMITED

Headquarters
Ahmedabad
Employees (FY)
182
Founded
1993
ISIN
INE551C01028
FIGI
BBG000DM6JG1
Shukra Pharmaceuticals Ltd. manufactures and markets pharmaceutical products in both domestic and international markets. Its portfolio includes antibiotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic. The company was founded on March 4, 1993 and is headquartered in Ahmedabad, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SHUKRAPHAR is 93.40 INR — it has increased by 1.97% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange SHUKRA PHARMACEUTICALS LIMITED stocks are traded under the ticker SHUKRAPHAR.
SHUKRAPHAR stock is 1.93% volatile and has beta coefficient of 4.00. Check out the list of the most volatile stocks — is SHUKRA PHARMACEUTICALS LIMITED there?
Yes, you can track SHUKRA PHARMACEUTICALS LIMITED financials in yearly and quarterly reports right on TradingView.
SHUKRAPHAR stock has risen by 10.21% compared to the previous week, the month change is a 12.12% rise, over the last year SHUKRA PHARMACEUTICALS LIMITED has showed a 307.42% increase.
SHUKRAPHAR net income for the last quarter is ‪94.22 M‬ INR, while the quarter before that showed ‪47.09 M‬ INR of net income which accounts for 100.07% change. Track more SHUKRA PHARMACEUTICALS LIMITED financial stats to get the full picture.
Yes, SHUKRAPHAR dividends are paid annually. The last dividend per share was 0.50 INR. As of today, Dividend Yield (TTM)% is 0.14%. Tracking SHUKRA PHARMACEUTICALS LIMITED dividends might help you take more informed decisions.
SHUKRA PHARMACEUTICALS LIMITED dividend yield was 1.07% in 2022, and payout ratio reached 1.91%. The year before the numbers were 0.83% and 10.43% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, SHUKRAPHAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHUKRA PHARMACEUTICALS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
SHUKRAPHAR reached its all-time high on Mar 7, 2024 with the price of 97.00 INR, and its all-time low was 1.20 INR and was reached on Nov 7, 2013.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 182.00 employees. See our rating of the largest employees — is SHUKRA PHARMACEUTICALS LIMITED on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHUKRA PHARMACEUTICALS LIMITED technincal analysis shows the strong buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHUKRA PHARMACEUTICALS LIMITED stock shows the buy signal. See more of SHUKRA PHARMACEUTICALS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SHUKRA PHARMACEUTICALS LIMITED EBITDA is ‪186.21 M‬ INR, and current EBITDA margin is 10.98%. See more stats in SHUKRA PHARMACEUTICALS LIMITED financial statements.